×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| CHEMO PHARMA LABORATORIES LTD. | -1.49 | -1.75 | NA | -1.17 | 11.9 | 29.8 |
| Vivanza Biosciences Limited | 15.11 | 0.43 | 15.01 | 0.01 | 10.9 | |
| UNJHA FORMULATIONS LTD. | 37.74 | 2.24 | 37.62 | 0.50 | 10.8 | 17.1 |
Chemo Pharma Laboratories Ltd.,, with Security Code 506365, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Expenses | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 |
| Operating Profit | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 |
| OPM % | 55% | 22% | 20% | 51% | 19% | 24% | 93% | 54% | 20% | 25% |
| Other Income | 0.6 | 0.2 | -0.1 | 0.4 | 0.5 | 0.7 | 0.2 | 0.3 | 0.6 | -0.1 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.6 | 0.2 | -0.1 | 0.5 | 0.5 | 0.7 | 0.3 | 0.4 | 0.7 | -0.1 |
| Tax % | 0.4% | 0% | -77.5% | 0% | 0% | 0% | 220.4% | 0% | 0% | 0% |
| Net Profit | 0.5 | 0.2 | -0.1 | 0.4 | 0.4 | 0.7 | -0.3 | 0.2 | 0.6 | -0.2 |
| EPS in Rs | 3.56 | 1.08 | -0.99 | 12.51 | 2.93 | 4.51 | -1.94 | 1.64 | 4.07 | -1.17 |
| Metrics |
|---|
| Sales |
| Expenses |
| Operating Profit |
| OPM % |
| Other Income |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| Net Profit |
| EPS in Rs |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 41% |
| 3 Years: | 68% |
| TTM: | -70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 60% |
| 3 Years: | 22% |
| 1 Year: | 1% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 60% |
| 3 Years: | 22% |
| 1 Year: | 1% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|